Back to User profile » Dr Somnath Chakraborty
Papers published by Dr Somnath Chakraborty:
Vitrectomy with Subretinal Tissue Plasminogen Activator for Submacular Hemorrhage: A Multicenter Retrospective Analysis of Functional and Anatomical Outcomes Across Multiple Etiologies
Chakraborty S, Sheth JU, Ganguly S, Reddy R
Clinical Ophthalmology 2026, 20:589150
Published Date: 9 March 2026
Twelve‑Month Response and Safety of Intravitreal Dexamethasone Implant in Treatment‑Naïve and Recalcitrant Diabetic Macular Edema (TREAT-DME Study)
Chakraborty S, Sheth JU, Ganguly S, Reddy R
Clinical Ophthalmology 2025, 19:4885-4895
Published Date: 24 December 2025
Efficacy and Safety of Intravitreal Brolucizumab in Chronic Central Serous Chorioretinopathy: A Retrospective Cohort Study [Response to Letter]
Chakraborty S, Sheth JU, Ganguly S, Reddy R
Clinical Ophthalmology 2025, 19:3851-3852
Published Date: 16 October 2025
Efficacy and Safety of Intravitreal Brolucizumab in Chronic Central Serous Chorioretinopathy: A Retrospective Cohort Study
Chakraborty S, Sheth JU, Ganguly S, Reddy R
Clinical Ophthalmology 2025, 19:3557-3565
Published Date: 26 September 2025
Fovea-Sparing Internal Limiting Membrane (ILM) Peeling and ILM Plug: A Novel Approach for Managing Optic Disc Pit Maculopathy
Chakraborty S, Sheth JU
Clinical Ophthalmology 2024, 18:3343-3351
Published Date: 19 November 2024
Comparative Analysis of Intravitreal Dexamethasone Implant (Ozurdex) and Brolucizumab Injection in the Treatment of Diabetic Macular Edema with Hyperreflective Intraretinal Dots: A Retrospective Study
Chakraborty S, Sheth JU
Clinical Ophthalmology 2024, 18:2897-2905
Published Date: 15 October 2024
Efficacy and Safety of an Indian Bevacizumab BIOSimilar (BEVATAS) for Retinal Vein Occlusion (BIOS-RVO Study)
Chakraborty S, Sheth JU
Clinical Ophthalmology 2024, 18:2865-2871
Published Date: 9 October 2024
Role of Intravitreal Dexamethasone Implant in the Management of Treatment-Naive Diabetic Macular Edema: A Pre-Cataract Surgical Approach for Patients with Systemic Contraindications to Anti-VEGF Therapy
Chakraborty S, Ganguly S, Sheth JU
Clinical Ophthalmology 2024, 18:227-233
Published Date: 23 January 2024
Efficacy of an Indian Bevacizumab BIOSimilar (BEVATAS) for Type 1 and Aggressive Posterior Retinopathy of Prematurity (BIOS-ROP Study)
Chakraborty S, Sheth JU
Clinical Ophthalmology 2024, 18:61-68
Published Date: 6 January 2024
Impact of COVID-19 Pandemic on Retinopathy of Prematurity Services in the Indian Public Healthcare System
Chakraborty S, Sheth JU
Clinical Ophthalmology 2023, 17:2871-2877
Published Date: 2 October 2023